Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a month
The Sensex fell 372 points on Monday, but nine BSE Midcap stocks touched fresh 52-week highs, signalling resilient investor confidence. Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services and Laurus Labs were among the key outperformers despite broader market weakness.
Stocks to Watch today: HCL Tech, HDFC Bank, Turtlemint, Hexaware Tech, IRFC
Stocks to Watch today, June 29: Tata Motors PV, Torrent Power, Dr Reddy's Laboratories, Aurobindo Pharma, KEC International, and Adani Ports are among the top stocks to watch during today's trade
Nifty has more room to run; stay selective: Analysts
Indian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommend selective trading and specific strategies like a moderately bullish Call Spread. Top stock picks include TVS Motor, Samvardhana Motherson International, Oberoi Realty, Aurobindo Pharma, Vijaya Diagnostic Centre, and Mahindra & Mahindra Financial Services, each presenting unique buying opportunities with defined targets and stop losses.
Stocks to Watch for June 29: HDFC Bank, Kotak Mahindra Bank, Dr Reddy’s and more
After an extended weekend, Dalal Street returns to a packed corporate news flow. From IRFC's successful OFS and Power Grid's fundraising plans to fresh developments at HDFC Bank, KEC International, Aurobindo Pharma and Bajaj Healthcare, here are the stocks likely to remain in focus on Monday.
Stocks to buy: Aurobindo Pharma, Delhivery, Ather Energy, says Ajit Mishra
Market outlook by Ajit Mishra: The analyst from Religare Broking expects Nifty to consolidate in the near-term; among stocks he recommends Delhivery, Ather Energy and Aurobindo Pharma.
Aurobindo Pharma Ltd leads losers in 'A' group
Ola Electric Mobility Ltd, Aster DM Healthcare Ltd, Data Patterns (India) Ltd and Shilpa Medicare Ltd are among the other losers in the BSE's 'A' group today, 15 June 2026.
Stocks to Watch today: RIL, Vedanta, ONGC, Suzlon Energy, Meesho, SEPC
Stock to Watch today, June 15, 2026: NLC India, Aurobindo Pharma, Dr Reddy's Labs, Ashoka Buildcon, JSW Energy, and Ather Energy are among the top stocks to watch during today's trading session
Rajesh Exports, Tata Motors PV, Auro Pharma, ICICI Bank and more: Stocks to Watch for June 5
Rajesh Exports defends disclosures after SEBI concerns, Tata Motors targets over 20% PV share by 2030, ICICI Bank gets SEBI warning, Aurobindo wins US FDA nod, CG Power starts new EHV unit. Here are few stocks to track ahead of Friday's trading session.
Stocks in news: Rajesh Exports, Lenskart, Suzlon Energy, Aurobindo Pharma, Tata Motors
Indian markets saw volatility and closed lower on Wednesday. Key companies are in focus due to significant developments. SoftBank reduced its stake in Lenskart. Sebi issued an interim order against Rajesh Exports. Tata Motors revised its Avinya EV strategy. Suzlon Energy is diversifying into battery storage. RIL's subsidiary signed MoUs with the Haryana Government.
Q4 Results LIVE Updates: Sanghvi Movers shares surge over 12%; Jubilant Foodworks down 7%
Q4 Results LIVE Updates: ITC, Aurobindo Pharma, LIC, LG Electronics, Ashoka Buildcon, Bikaji Foods, Datamatics, Engineers India, GMM Pfaudler, Happy Forgings, Honasa Consumer, Ixigo, Nykaa, Page Industries, Ramco Cements, Max Healthcare, Prestige Estates, MTNL, Sun TV, Quick Heal, RCF, WeWork, VA Tech Wabag, are among the companies reporting their earnings today. The street will also react to numbers reported by Whirlpool, Apollo Hospitals, Sammaan Capital, JK Lakshmi Cement, Lenskart, Ola Electric and others. Watch this space for all the LIVE earnings updates.
Stock picks: Analyst prefer Aurobindo Pharma, Sona BLW, Tata Steel
Stock picks: Ajit Mishra of Religare Broking recommends buying Aurobindo Pharma, Tata Steel & Sona BLW; here's why
Aurobindo Pharma approves ₹800 crore share buyback; Check premium, record date and more
This is Aurobindo Pharma's first share buyback in nearly two years. Back in August 2024, the company had announced the repurchase of 51.36 lakh equity shares at a price of ₹1,460 apiece. The drugmaker had spent ₹750 crore for this buyback, which was also carried out via the tender offer route.